Page last updated: 2024-10-24

rhythmic synaptic transmission

Definition

Target type: biologicalprocess

Any process involved in the generation of rhythmic, synchronous synaptic inputs in a neural circuit. [GOC:dph]

Rhythmic synaptic transmission is a fundamental process in the nervous system that enables the coordinated and rhythmic firing of neurons. It is essential for various physiological functions, including sensory perception, motor control, and circadian rhythms. This process involves the precise and repetitive release of neurotransmitters from presynaptic neurons, triggering postsynaptic responses that occur in a rhythmic pattern.

The orchestration of rhythmic synaptic transmission relies on a complex interplay of molecular mechanisms and cellular signaling pathways. Key elements include:

1. **Presynaptic Calcium Oscillations:** Rhythmic synaptic transmission is often driven by oscillations in intracellular calcium concentration within presynaptic terminals. These oscillations can be generated by various mechanisms, including:
- **Voltage-dependent calcium channels:** These channels open in response to depolarization of the presynaptic membrane, allowing calcium influx into the terminal.
- **Calcium-induced calcium release:** Calcium entry through voltage-dependent channels can trigger the release of calcium from intracellular stores, further amplifying calcium signals.
- **Synaptic activity-dependent mechanisms:** The repeated firing of presynaptic neurons can lead to the accumulation of calcium in the terminal, contributing to sustained oscillations.

2. **Synaptic Vesicle Cycling:** The rhythmic release of neurotransmitters is tightly coupled to the cycling of synaptic vesicles, which are membrane-bound organelles containing neurotransmitters. This cycling involves:
- **Docking:** Synaptic vesicles are tethered to the presynaptic membrane at specialized release sites.
- **Priming:** Docked vesicles are primed for rapid release, becoming readily available for calcium-mediated exocytosis.
- **Fusion and Neurotransmitter Release:** Upon calcium influx, primed vesicles fuse with the presynaptic membrane, releasing their neurotransmitter content into the synaptic cleft.
- **Endocytosis:** After neurotransmitter release, the vesicle membrane is retrieved through endocytosis, forming new vesicles that can be refilled with neurotransmitter.

3. **Postsynaptic Signaling:** The rhythmic release of neurotransmitters triggers a corresponding rhythmic activation of postsynaptic receptors. These receptors can be ionotropic, directly altering membrane permeability, or metabotropic, triggering intracellular signaling cascades.

4. **Modulation of Rhythmic Transmission:** The frequency and amplitude of rhythmic synaptic transmission can be modulated by various factors, including:
- **Presynaptic factors:** The number and type of calcium channels, the availability of synaptic vesicles, and the presence of presynaptic receptors can influence transmission.
- **Postsynaptic factors:** The density and sensitivity of postsynaptic receptors can determine the strength of the postsynaptic response.
- **Extrinsic factors:** Neurotransmitters, neuromodulators, and hormonal signals can modulate rhythmic synaptic transmission, altering its frequency, amplitude, and duration.

Rhythmic synaptic transmission plays a crucial role in a wide range of brain functions. For example, it is essential for:

- **Sensory Processing:** Rhythmic transmission underlies the processing of sensory information, such as auditory perception and visual motion detection.
- **Motor Control:** Rhythmic firing of motor neurons contributes to coordinated muscle movements, including walking and breathing.
- **Learning and Memory:** Rhythmic activity patterns in neuronal circuits are thought to be involved in memory formation and consolidation.
- **Circadian Rhythms:** The rhythmic firing of neurons in the suprachiasmatic nucleus, the brain's internal clock, generates daily rhythms in behavior and physiology.

Dysregulation of rhythmic synaptic transmission can contribute to various neurological disorders, including epilepsy, Parkinson's disease, and Alzheimer's disease. Research into the mechanisms underlying rhythmic transmission provides valuable insights into the normal functioning of the nervous system and offers potential targets for therapeutic interventions in neurological disorders.
'"

Proteins (2)

ProteinDefinitionTaxonomy
Voltage-dependent calcium channel subunit alpha-2/delta-2A voltage-dependent calcium channel subunit alpha-2/delta-2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9NY47]Homo sapiens (human)
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTENA phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN that is encoded in the genome of human. [PRO:PD, UniProtKB:P60484]Homo sapiens (human)

Compounds (6)

CompoundDefinitionClassesRoles
tacrinetacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.

Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
acridines;
aromatic amine
EC 3.1.1.7 (acetylcholinesterase) inhibitor
nimodipinenimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
2-methoxyethyl ester;
C-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
isopropyl ester
antihypertensive agent;
calcium channel blocker;
cardiovascular drug;
vasodilator agent
celastrolmonocarboxylic acid;
pentacyclic triterpenoid
anti-inflammatory drug;
antineoplastic agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Hsp90 inhibitor;
metabolite
reboxetineReboxetine: A morpholine derivative that is a selective and potent noradrenaline reuptake inhibitor; it is used in the treatment of DEPRESSIVE DISORDER.aromatic ether
pregabalinpregabalin : A gamma-amino acid that is gamma-aminobutyric acid (GABA) carrying an isobutyl substitutent at the beta-position (the S-enantiomer). Binds with high affinity to the alpha2-delta site (an auxiliary subunit of voltage-gated calcium channels) in central nervous system tissues.

Pregabalin: A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA.
gamma-amino acidanticonvulsant;
calcium channel blocker
ith 4012